Pharmaust finds buyer for CBI
Tuesday, 10 June, 2008
WA generic medicines company Pharmaust (ASX: PAA) has found a buyer for its share in Commonwealth Biotechnologies Inc (CBI), a US-based life sciences R&D outsourcing specialist.
In a statement, Pharmaust's board said it had decided that ownership of the shares was doing nothing to help the company's bottom line, but had run into difficulties selling the shares.
The shares were unregistered, meaning they could not be sold on the NASDAQ exchange and had to be sold privately.
The company has finally sourced a likely buyer, Hong Kong-based Venturepharm Laboratories.
Pharmaust shareholders will be asked to vote on the deal on July 11.
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
